Celiac Disease: Gaps, Disagreements and Challenges, Course #23D06 - 8/17/2022 ABP MOC

Wednesday, August 17, 2022, 12:15 PM - 1:15 PM, Samis Education Center, Oklahoma City, OK

Pediatrics is a diverse specialty area encompassing all the systems of the body, and includes generalists and sub-specialists. Grand rounds is a weekly one hour presentation incorporating active learning techniques including: case studies, the audience responds to questions with audience response systems, small group discussions, panel discussions, and question and answer opportunities. Because of the diversity of pediatrics and the wide range of diverse clinical cases seen, a wide variety of topics are presented which are relevant to both generalists and sub-specialists.

Overall Program Professional Practice Gap:
Since general pediatrics is a diverse field with regularly changing, best-practice and guidelines, primary care physicians do not always recognize and know the most current approaches to care of all children with special health care needs.

Session Professional Practice Gaps: 
Gap 1: Practitioners might not know the difference between the usefulness of different serological tests for celiac disease and the rationale for preferring one test over the other.
Gap 2: Practitioners might not be aware of the high-risk group of the population which need to be screened for celiac disease.
Gap 3: Practitioners need to be made aware that genetic testing should not be done routinely to diagnose celiac disease.

Learning Objectives:  Upon completion of this session, participants will improve their competence and performance by being able to: 
•Discuss the rationale behind using different screening tests for celiac disease, based on their pretest probabilities and in the context of specific clinical needs  
•Identify the high-risk group for having celiac disease and implement the strategy to introduce celiac disease screening
•Support that genetic testing has very limited role in the diagnostic algorithm for celiac disease. It should not be used routinely and must be reserved for specific clinical situations to rule out celiac disease

Download Announcement

1. Discuss the rationale behind using different screening tests for celiac disease, based on their pretest probabilities and in the context of specific clinical needs
2. Identify the high-risk group for having celiac disease and implement the strategy to introduce celiac disease screening
3. Support that genetic testing has very limited role in the diagnostic algorithm for celiac disease. It should not be used routinely and must be reserved for specific clinical situations to rule out celiac disease

The University of Oklahoma College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Oklahoma College of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Mitigation Statement: The University of Oklahoma College of Medicine, Office of Continuing Professional Development has reviewed this activity’s speaker and planner disclosures and has mitigated all relevant financial relationships with ineligible companies, if applicable.

Nondiscrimination Statement:
The University of Oklahoma, in compliance with all applicable federal and state laws and regulations, does not discriminate on the basis of race, color, national origin, sex, sexual orientation, genetic information, gender identity, gender expression, age, religion, disability, political beliefs, or status as a veteran in any of its policies, practices, or procedures. This includes, but is not limited to: admissions, employment, financial aid, housing, services in educational programs or activities, or health care services that the university operates or provides. Inquiries regarding non-discrimination policies may be directed to: Shaniqua Crawford, JD, Institutional Equity Officer and Title IX Coordinator, 405-325-3546, [email protected], or visit www.ou.edu/eoo.html. 

Accommodation Statement:
Accommodations on the basis of disability are available by contacting (insert Course Contact) at (405) xxx-xxxx or (insert email address) as soon as possible.

Acknowledgement of Commercial and In-Kind Support:
Commercial support is financial, or in-kind, contributions given by a ineligible company, which is used to pay all or part of the costs of a CME activity.  An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. 

Appropriate acknowledgement of all commercial and in-kind support will be given at the time of the educational activity.

Disclaimer Statement:
Statements, opinions and results of studies contained in the program are those of the presenters and authors and do not reflect the policy or position of the Board of Regents of the University of Oklahoma (“OU”) nor does OU provide any warranty as to their accuracy or reliability.

Every reasonable effort has been made to faithfully reproduce the presentations and material as submitted. However, no responsibility is assumed by OU for any claims, injury and/or damage to persons or property from any cause, including negligence or otherwise, or from any use or operation of any methods, products, instruments or ideas contained in the material herein.

Policy on Faculty and Presenters Disclosure: 
It is the policy of the University of Oklahoma College of Medicine that the faculty and presenters identify all financial relationships with ineligible companies relating to the topics of this educational activity, and also disclose discussions of off-label or investigational drugs/devices and/or therapies during their presentation(s). 

AMA PRA Category 1 Credits™ (1.00 hours), ABP MOC Part 2 (1.00 hours), Non-Physician Attendance (1.00 hours)

Mitigation of Relevant Financial Relationships

The University of Oklahoma College of Medicine, Office of Continuing Professional Development has reviewed this activity’s speaker and planner disclosures and has mitigated all relevant financial relationships with ineligible companies, if applicable.

Date	Empty Column	Title
		No activities are currently published for this month.
No upcoming dates have been setup.